<DOC>
	<DOCNO>NCT00139607</DOCNO>
	<brief_summary>This phase III , multicenter , open label , pilot evaluate analgesic efficacy safety parecoxib 40 mg IV treatment pain follow hemicolectomy optimal management surgical patient</brief_summary>
	<brief_title>Parecoxib In Post Surgery ( Hemicolectomy ) Pain</brief_title>
	<detailed_description>The study terminate prematurely due recruitment issue 31 January 2006 . Safety concern lead decision terminate study .</detailed_description>
	<mesh_term>Parecoxib</mesh_term>
	<criteria>patient hospitalise resection left/right colon ; preoperative health grade ASA &lt; 3 . patient type metastatic cancer , particularly metastatic colon cancer ; patient familial adenomatous polyp ( sporadic adenomatous polyp accept ) ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2009</verification_date>
</DOC>